501 - 525 of 7916 Results
Title
Year
-
OPENTitle: A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 12Start Page: 113544End Page: 113544Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2023.113544Best OA location URL: http://www.cell.com/article/S2211124723015565/pdfCitation Count: 4
-
OPENTitle: Cell-free RNA signatures predict Alzheimer’s diseaseJournal Name: iSciencePublisher: Elsevier BVVol: 26Issue #: 12Start Page: 108534End Page: 108534Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2023.108534Best OA location URL: http://www.cell.com/article/S2589004223026111/pdfCitation Count: 2
- Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)2023OPENTitle: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)Journal Name: IBRO Neuroscience ReportsPublisher: Elsevier BVVol: 15Issue #:Start Page: 320End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001Best OA location URL: http://www.ibroneuroreports.org/article/S2667242123022716/pdfCitation Count: 0
-
RESTRICTEDTitle: Cytokine activity in Parkinson's diseaseJournal Name: Neuronal SignalingPublisher: Portland Press Ltd.Vol: 7Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/ns20220063Best OA location URL: https://portlandpress.com/neuronalsignal/article-pdf/doi/10.1042/NS20220063/951916/ns-2022-0063c.pdfCitation Count: 0
- In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids2023OPENTitle: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloidsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 12Start Page: 2034End Page: 2047Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41592-023-02080-xBest OA location URL: https://www.nature.com/articles/s41592-023-02080-x.pdfCitation Count: 12
- Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures2023OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adk6191?download=trueCitation Count: 11
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease2023OPENTitle: Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 704End Page: 717Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s11481-023-10094-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-023-10094-7.pdfCitation Count: 2
-
OPENTitle: Predicting cognitive decline in a low‐dimensional representation of brain morphologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: S10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.081611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.081611Citation Count: 0
- Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivo2023RESTRICTEDTitle: Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivoJournal Name: Current Opinion in Chemical BiologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 102403End Page: 102403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cbpa.2023.102403Citation Count: 0
- The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski2023OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
- Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection2023OPENTitle: Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selectionJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2023.1293847Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2023.1293847/pdf?isPublishedV2=FalseCitation Count: 1
- Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complex2023OPENTitle: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complexJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231209411Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15353702231209411Citation Count: 6
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645.2Best OA location URL: https://doi.org/10.7554/elife.91645.2Citation Count: 12
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adi8716?download=trueCitation Count: 46
- In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker2023OPENTitle: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy BiomarkerJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 22Start Page: 16445End Page: 16445Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms242216445Best OA location URL: https://www.mdpi.com/1422-0067/24/22/16445/pdf?version=1700208971Citation Count: 0
-
RESTRICTEDTitle: Association of liver fibrosis with cognitive decline in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 119Issue #:Start Page: 10End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2023.11.019Citation Count: 0
-
RESTRICTEDTitle: Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodiesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 1Start Page: 255End Page: 266Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awad391Citation Count: 3
- Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy2023OPENTitle: Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1280218Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1280218/pdf?isPublishedV2=FalseCitation Count: 0
-
OPENTitle: Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2269End Page: 2281Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29611Citation Count: 2
- Total-Body Irradiation Alters White Matter Volume and Microstructural Integrity in Rhesus Macaques2023RESTRICTEDTitle: Total-Body Irradiation Alters White Matter Volume and Microstructural Integrity in Rhesus MacaquesJournal Name: International Journal of Radiation Oncology*Biology*PhysicsPublisher: Elsevier BVVol: 119Issue #: 1Start Page: 208End Page: 218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ijrobp.2023.11.014Citation Count: 2
- Evaluating the Utility of REVEL and CADD for Interpreting Variants in Amyotrophic Lateral Sclerosis Genes2023OPENTitle: Evaluating the Utility of REVEL and CADD for Interpreting Variants in Amyotrophic Lateral Sclerosis GenesJournal Name: Human MutationPublisher: WileyVol: 2023Issue #:Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2023/8620557Best OA location URL: https://downloads.hindawi.com/journals/humu/2023/8620557.pdfCitation Count: 0
- Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model2023OPENTitle: Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse modelJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-42876-1Best OA location URL: https://www.nature.com/articles/s41467-023-42876-1.pdfCitation Count: 10
-
OPENTitle: A genetic and transcriptomic assessment of the KTN1 gene in Parkinson’s disease riskJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 134Issue #:Start Page: 66End Page: 73Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2023.11.001Best OA location URL: https://doi.org/10.1101/2021.03.08.21252688Citation Count: 0
-
RESTRICTEDTitle: Enduring questions in regenerative biology and the search for answersJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-023-05505-7Best OA location URL: https://www.nature.com/articles/s42003-023-05505-7.pdfCitation Count: 0
-
OPENTitle: Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 3Start Page: 1483End Page: 1491Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-023-12073-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-023-12073-7.pdfCitation Count: 5